Dr Grace Kim, recognised specialist in financial strategy and investor relations in the biopharmaceutical sector

Next PostPhase 1 data of mdc-TJK investigational long-acting injectable of olanzapine for schizophrenia patients, exhibited favorable characteristics of an extended-release profile